STOCK TITAN

Leidos Holdings, Inc. - LDOS STOCK NEWS

Welcome to our dedicated page for Leidos Holdings news (Ticker: LDOS), a resource for investors and traders seeking the latest updates and insights on Leidos Holdings stock.

Leidos Holdings, Inc. (NYSE: LDOS) is a leading science and technology company that provides services and solutions in defense, intelligence, civil, and health markets. Headquartered in Reston, Virginia, Leidos leverages the expertise of its 47,000 employees to tackle some of the world's most pressing challenges. The company is divided into several segments, each catering to specific industries:

  • National Security and Digital: Focuses on cyber, logistics, security operations, and digital transformation for defense and intelligence customers.
  • Health & Civil: Delivers public health solutions, care coordination, and environmental sciences services.
  • Commercial & International: Covers security enterprise solutions, commercial energy offerings, and international business.
  • Defense Systems: Develops advanced space, aerial, surface, and subsurface defense systems.

Leidos reported revenues of approximately $15.4 billion for the fiscal year ending December 29, 2023. The company’s recent projects include:

  • Development of C2IMERA: An advanced command and control tool for the U.S. Air Force.
  • MHS GENESIS Deployment: A federal electronic health record system implemented across all Department of Defense garrison facilities.
  • Mayhem Hypersonic System: Advancing air-breathing hypersonic technologies through a collaborative national team effort.

Financially, Leidos had a strong 2023 with revenues up by 7%, achieving a record net income margin of 7.1% in the first quarter of 2024. The company remains committed to innovation, operational efficiency, and addressing emerging threats in national security and health.

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.38%
Tags
none
-
Rhea-AI Summary

Brooks Automation, Inc. (Nasdaq: BRKS) announced a new contract with QTC Management, a Leidos company (NYSE: LDOS), to provide vaccine storage and distribution for the U.S. Department of Defense. This collaboration supports QTC's Reserve Health Readiness Program III, ensuring secure cold storage of vaccines and timely delivery across the U.S. and Germany. Azenta Life Sciences, the rebranded segment of Brooks, will leverage its expertise in cold-chain services to meet stringent requirements. This strategic move reflects Brooks' focus on expanding its Life Sciences business.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.19%
Tags
none
-
Rhea-AI Summary

Leidos Holdings (LDOS) reported a strong Q3 2021, with revenues reaching $3.48 billion, up 7% year-over-year. Net income increased 28% to $208 million, leading to diluted EPS of $1.43. Adjusted EBITDA rose 16% to $403 million, with an increased margin of 11.6%. The company recorded $4.7 billion in net bookings, resulting in a backlog of $34.7 billion. Leidos updated its FY21 guidance, projecting revenues between $13.7-$13.9 billion and non-GAAP diluted EPS of $6.55-$6.75.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.95%
Tags
Rhea-AI Summary

Leidos (NYSE:LDOS) has been awarded a task order by the Air Combat Command (ACC) Acquisition Management and Integration Center, valued at approximately $531 million if all options are exercised. The contract includes a one-year base period and four one-year options, focusing on intelligence, surveillance, and reconnaissance (ISR) operations. Leidos will provide expertise and support services at over 25 locations. This contract emphasizes Leidos' strategic role in enhancing ACC's operational capabilities, leveraging over 33 years of experience in defense intelligence.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.95%
Tags
-
Rhea-AI Summary

Leidos Holdings, Inc. (NYSE:LDOS) has announced a quarterly cash dividend of $0.36 per share, payable on December 30, 2021. To qualify, stockholders must be on record by the close of business on December 15, 2021. This decision reflects Leidos' ongoing commitment to return value to shareholders. The company, a leader in technology and engineering, reported annual revenues of approximately $12.30 billion for the fiscal year ending January 1, 2021, and employs around 43,000 individuals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.17%
Tags
dividends
-
Rhea-AI Summary

Leidos (NYSE: LDOS) has been awarded a prime contract by the Office of Naval Intelligence (ONI) for approximately $65 million to support the Hopper Information Services Center. This contract includes professional IT services like cloud migration, software development, and cybersecurity, primarily based in Suitland, Maryland. Leidos aims to enhance the U.S. naval forces' information advantage through this agreement, building on decades of collaboration with ONI.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.81%
Tags
none
Rhea-AI Summary

Leidos (NYSE: LDOS) has announced a conference call to discuss its third-quarter financial results for the period ending October 1, 2021. The call is scheduled for November 2, 2021, at 8 a.m. ET, with the earnings press release set to be issued prior to the call. Investors can access the conference via the internet or telephone. The company reported approximately $12.30 billion in annual revenues for the fiscal year ending January 1, 2021, serving government and commercial clients across defense, intelligence, civil, and health markets.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.58%
Tags
-
Rhea-AI Summary

Leidos (NYSE: LDOS) has been awarded a five-year contract by the National Security Agency (NSA) with a ceiling value of $300 million. This contract supports the NSA's Technical Signals Intelligence (TechSIGINT) modernization efforts. Leidos will leverage its technical and engineering expertise to develop and deploy new systems using cloud architectures, enhancing capabilities in TechSIGINT collection, production, and analysis. The company reported annual revenues of approximately $12.30 billion for the fiscal year ending January 1, 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.54%
Tags
none
-
Rhea-AI Summary

On October 5, 2021, Leidos (NYSE:LDOS) recognized its suppliers at the 2021 Supplier Innovation & Technology Symposium. Awards included Alliance Partner of the Year going to Amazon Web Services, Innovation Partner of the Year awarded to Intel, and VAR of the Year to COLAMCO Inc.. The symposium celebrated suppliers for their role in enhancing Leidos' mission to create safer and more efficient solutions. Bob Gemmill, Senior VP at Leidos, highlighted the resilience and innovation of suppliers during challenging global supply chain dynamics.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.47%
Tags
none
Rhea-AI Summary

Leidos (NYSE:LDOS) has secured a prime contract with U.S. Customs and Border Protection (CBP) for Low-Energy Portal systems, aimed at enhancing non-intrusive vehicle inspections at U.S.-Mexico border crossings. The contract has a ceiling value of $390 million, with an initial order worth $107 million. This project complements the previously awarded Multi-Energy Portal program, valued at $480 million, further expanding CBP's capabilities in securing borders against smuggling and illegal activities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.86%
Tags
none

FAQ

What is the current stock price of Leidos Holdings (LDOS)?

The current stock price of Leidos Holdings (LDOS) is $145.2 as of December 23, 2024.

What is the market cap of Leidos Holdings (LDOS)?

The market cap of Leidos Holdings (LDOS) is approximately 19.2B.

What does Leidos Holdings, Inc. do?

Leidos Holdings, Inc. provides technology, engineering, and science solutions in defense, intelligence, civil, and health markets.

Where is Leidos Holdings, Inc. headquartered?

Leidos Holdings, Inc. is headquartered in Reston, Virginia.

How many employees does Leidos have?

Leidos employs approximately 47,000 people.

What are the main business segments of Leidos?

Leidos operates in four main segments: National Security and Digital, Health & Civil, Commercial & International, and Defense Systems.

What were Leidos' revenues for the fiscal year 2023?

Leidos reported revenues of approximately $15.4 billion for the fiscal year ending December 29, 2023.

What is C2IMERA?

C2IMERA is an advanced command and control tool developed by Leidos for the U.S. Air Force.

What is MHS GENESIS?

MHS GENESIS is a federal electronic health record system deployed by Leidos across all Department of Defense garrison facilities.

What recent project has Leidos completed for the Air Force Research Lab?

Leidos successfully completed key reviews for the Mayhem air-breathing hypersonic system for the Air Force Research Lab.

What are the recent financial highlights for Leidos?

For the first quarter of 2024, Leidos reported a record net income margin of 7.1% and revenues of $3.98 billion.

How does Leidos contribute to national security?

Leidos provides advanced technology solutions for defense and intelligence clients, including cybersecurity, logistics, and security operations.

Leidos Holdings, Inc.

NYSE:LDOS

LDOS Rankings

LDOS Stock Data

19.19B
131.91M
1.04%
78.75%
1.43%
Information Technology Services
Services-computer Integrated Systems Design
Link
United States of America
RESTON